
Prophylactic Administration of Recombinant Human Thrombopoietin in the Secondary Prevention of Thrombocytopenia Induced by XELOX Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer: Erratum
Publication year - 2021
Publication title -
american journal of therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.349
H-Index - 62
eISSN - 1536-3686
pISSN - 1075-2765
DOI - 10.1097/mjt.0000000000001457
Subject(s) - medicine , thrombopoietin , adjuvant chemotherapy , colorectal cancer , adjuvant , chemotherapy , oncology , stage (stratigraphy) , recombinant dna , gastroenterology , cancer , breast cancer , gene , paleontology , biochemistry , chemistry , genetics , stem cell , haematopoiesis , biology